Copper Biodistribution
Copper Biodistribution - Related Videos
13:29
Biodistribution of Nano-drug Carriers: Applications of SEM
0 Views •
2023
Source: Peiman Shahbeigi-Roodposhti and Sina Shahbazmohamadi, Biomedical Engineering Department, University of Connecticut, Storrs, Connecticut Nanoparticles have been increasingly used research towards targeted drug delivery and controlled drug release. While most of these particles have been developed as polymeric or liposomal particles because of their biocompatibility, there is a trend in current research toward the use of metallic and magnetic nanoparticles. These metallic nanoparticles...
06:15
An In Vivo Immunofluorescence Localization Method to Study Antibody Biodistribution
0 Views •
2025
This video demonstrates an in vivo immunofluorescence localization (IVIL) technique to study the biodistribution of tumor-targeting antibodies in a murine model of breast cancer. Upon the intravenous injection of a tumor-specific antibody in the mouse, the tumor is surgically isolated, and the localization of the antibody within the tumor tissue is confirmed via ex vivo immunostaining.
06:52
Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
0 Views •
Cited by 6 •
2023
The present protocol describes how to perform 64Cu PET/CT and PET/MRI imaging in humans to study copper-related disorders, such as Wilson disease, and the treatment effect on copper metabolism.
06:45
A Caenorhabditis elegans Nutritional-status Based Copper Aversion Assay
0 Views •
Cited by 3 •
2017
Here, we present a Caenorhabditis elegans-specific assay designed to evaluate changes in copper aversion behavior and the ability to locate a common food source, as the organism progresses from a well-fed to starved nutritional state.
13:35
Acute and Chronic Models of Hyperglycemia in Zebrafish: A Method to Assess the Impact of Hyperglycemia on Neurogenesis and the Biodistribution of Radiolabeled Molecules
0 Views •
Cited by 25 •
2017
This work describes methods to establish acute and chronic hyperglycemia models in zebrafish. The aim is to investigate the impact of hyperglycemia on physiological processes, such as constitutive and injury-induced neurogenesis. The work also highlights the use of zebrafish to follow radiolabeled molecules (here, [18F]-FDG) using PET/CT.
FAQs
The liver acts as a central decision point for newly absorbed copper. Copper arriving through the portal circulation can be incorporated into ceruloplasmin, a carrier protein that supports distribution to peripheral tissues, or directed toward biliary excretion. This branching helps coordinate copper delivery with removal and is therefore important when interpreting systemic copper levels or altered copper handling.
These components control copper movement at different stages. Carrier proteins support circulation, transporters regulate entry into or movement between cells, and chaperone proteins guide copper to appropriate cellular destinations. Their coordinated activity helps direct copper toward enzymes, connective tissues, blood formation, and nervous-system functions while limiting uncontrolled accumulation that could contribute to toxicity.
Copper supports several essential biological functions, but excess copper can become toxic. Effective regulation therefore requires a balance between intestinal uptake, protein-bound transport, tissue delivery, storage or use, and elimination. Studying where copper accumulates or is removed helps identify disruptions in this balance and clarifies how altered handling may affect multiple organ systems.
Copper Biodistribution provides a framework for examining why copper may fail to reach, remain within, or leave particular body compartments in Wilson disease and Menkes disease. Mapping copper movement across the absorption, transport, liver-processing, tissue-delivery, and elimination stages can connect disease-associated abnormalities with their effects on copper availability and accumulation.
Such a study can show how a copper-containing therapeutic or radiotracer is distributed after entering the body, including its relationship to liver processing and peripheral tissue delivery. This information helps investigators assess whether the material reaches intended biological compartments, follows expected clearance pathways, or displays distribution patterns relevant to safety and effectiveness.
Distribution data can indicate whether a treatment should influence copper uptake, transport, tissue delivery, hepatic processing, or elimination. In medicine, this supports evaluation of approaches designed to improve copper availability when delivery is inadequate or increase removal when copper accumulates. The same framework also helps assess how interventions affect ceruloplasmin formation and biliary excretion.